A postdoctoral position is available in the laboratory of Gordon Freeman in the Department of Medical Oncology at the Dana-Farber Cancer Institute, Harvard Medical School. The lab focuses on costimulatory and coinhibitory pathways, particularly the PD-L1/PD-1 and HHLA2/KIR3DL3 pathways.
Located in Boston and the surrounding communities, Dana-Farber Cancer Institute is a leader in life changing breakthroughs in cancer research and patient care. We are united in our mission of conquering cancer, HIV/AIDS and related diseases. We strive to create an inclusive, diverse, and equitable environment where we provide compassionate and comprehensive care to patients of all backgrounds, and design programs to promote public health particularly among high-risk and underserved populations. We conduct groundbreaking research that advances treatment, we educate tomorrow’s physician/researchers, and we work with amazing partners, including other Harvard Medical School-affiliated hospitals.
Responsibilities
This position will involve examining the role of PD-1 and other coinhibitory pathways in immune responses and particularly on therapeutic synergies of coinhibitory blockade for anti-tumor immunity. A background in immunology and mouse tumor models is essential. Relevant experience in working with T cells, antigen-presenting cells, cell culture, immunological techniques and multicolor flow cytometry are highly desirable.
Qualifications
The ideal candidate will be a self-starter capable of generating new ideas with strong work ethic and intensely curious with a love of discovery.
Candidates should have a Ph.D. and/or M.D.
At Dana-Farber Cancer Institute, we work every day to create an innovative, caring, and inclusive environment where every patient, family, and staff member feels they belong. As relentless as we are in our mission to reduce the burden of cancer for all, we are equally committed to diversifying our faculty and staff. Cancer knows no boundaries and when it comes to hiring the most dedicated and diverse professionals, neither do we. If working in this kind of organization inspires you, we encourage you to apply.
Dana-Farber Cancer Institute is an equal opportunity employer and affirms the right of every qualified applicant to receive consideration for employment without regard to race, color, religion, sex, gender identity or expression, national origin, sexual orientation, genetic information, disability, age, ancestry, military service, protected veteran status, or other characteristics protected by law.
